Gabby M, Tauber M, Porat S, Simantov R
As GLP1 receptor agonists move into broader use for obesity and cardiometabolic risk reduction the need for cross specialty collaboration becomes paramount.The discussion around 'disc at risk' underscores the importance of baseline risk stratification
[11] Eli Lilly and Company
Third, it travels to the brain, dialing down hunger and signalling, Youre full. But in diabetic patients, particularly type-2 diabetes, this turns into something of a chaos
Depending on an individuals response and as advised by the doctor, the dosage may be incrementally increased
For those considering these medications, working with a healthcare provider is essential to manage side effects, address nutritional needs, and tailor treatment plans effectively